Respiratory Distress Syndrome, Adult, Septic Shock
Conditions
Keywords
IVIG, ARDS, ECMO
Brief summary
57 patients with Adult Respiratory Distress Syndrome (ARDS) requiring Extracorporeal membrane oxygenation (ECMO) therapy were analyzed retrospectively. 28 patients had received immunglobulin M-enriched immunoglobulin therapy (IVIG); 29 patients did not receive IVIG therapy. These patients were analyzed regarding length of stay in intensive care unit (LOS ICU), length of stay (LOS) in hospital and regarding mortality.
Detailed description
57 patients with ARDS requiring ECMO therapy were analyzed retrospectively. 28 patients had received IgM-enriched immunoglobulin therapy (IVIG); 29 patients did not receive IVIG therapy. Patient characteristics, like Acute Physiology And Chronic Health Evaluation (APACHE) and Sepsis-related organ failure assessment (SAPS) Score, preexisting diseases, origin of infection, duration of ECMO therapy were analyzed in these patients. These patients were further analyzed regarding LOS ICU, LOS in hospital and regarding mortality.
Interventions
DRUGIgM enriched Immunoglobulins
Treatment for 3 days
Sponsors
Universität Tübingen
University Hospital Tuebingen
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* All data available * ARDS with ECMO therapy
Exclusion criteria
* Data missing
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mortality | during ICU treatment, up to 28 days | Death during ICU therapy |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| lengh of stay (LOS ICU) | up to 60 days | lengh of stay on ICU in days |
Countries
Germany
Outcome results
None listed